All News

Research shows a peak of highly cited COVID-19 studies at the end of 2021 and a significant downward trend by the end of 2022.

Strategies include improving compliance, convenience, symptom management, and reducing stigma around pre-exposure prophylaxis for HIV.

Nuances can lead to frequent areas of confusion.

Combining strong evidence-based recommendations with caring, compassionate, and frequent counseling opportunities hopefully will increase vaccine acceptance and ultimately reduce the incidence of HPV and associated cancers among our patients.

Improved classification of different lymphoma types can improve the potential of targeted therapies and help predict patient responses.

Pharmacist successfully mounts challenge to that limitation.

Most patients with myelofibrosis will develop anemia over the course of the disease, with more than 30% discontinuing treatment as a result.

Experts answer questions on influenza vaccines.

In this episode of Pharmacy Focus: Student Edition, we dive deep into the world of scholarship funds from Good Neighbor Pharmacy and Cencora, designed to support Black student pharmacists.

As research and clinical experience continue, Hemangeol's role in the management of infantile hemangioma is likely to expand, further improving the lives of affected children.

Although antibiotics are the standard-of-care treatment for Clostridioides difficile infection, they can cause further microbiota changes that predispose patients to recurrence.

Community pharmacies and organizations can collaborate to tailor strategies and interventions and address the challenges and specific needs of the community.

A collaborative exercise with 16 health care organizations nets millions in savings.

With some of the most effective antidepressants containing a black box warning, safe and effective treatment for young adults is hard to come by.

Bispecific antibodies have 2 distinct binding domains, which interact with either CD3 on T cells or a tumor-associated antigen on the tumor cell surface.

Products include Cyanocobalamin Nasal Spray, Chlorpromazine Hydrochloride Tablets USP, Tiotropium Bromide Inhalation Powder, 18 mcg/ capsule, and Sevelamer Hydrochloride Tablets USP.

As a once-daily oral treatment, orforglipron could help address barriers to injectable medications, such as semaglutide and liraglutide.

Expert panelists addressed concerns about the COVID-19 vaccine costs, availability, efficacy, and timing.

The "interchangeable" designation has created confusion around the difference between biosimilars designated as interchangeable and those that are not.

AI is able to quickly analyze, identify, and route data for investigation.

Products include Nirsevimab-alip, Remdesivir, Inclisiran, and Lecanemab-irmb.

By educating their patients on the provisions of the Inflation Reduction Act, pharmacists can have an even greater impact by increasing vaccine uptake in historically underserved groups.

Heart disease prevention efforts should acknowledge non-biological factors that can cause issues within cardiovascular health rather than relying on decreasing socioeconomic disparities.

Clinicians raise concerns about immunogenicity, product quality, and reimbursement for biosimilars.

Compared with COVID-19 vaccination alone, recent study findings show health care workers who received both a COVID-19 booster and influenza vaccinations did not have lower immune response or more frequent adverse events.

The act would have permitted health care facilities to stock up on compounded medications without forcing the supplying 503A pharmacies to register as outsourcing facilities.

The use of gefapixant reduces cough frequency but increases adverse events in individuals suffering from a chronic cough.

The use of base editing to generate universal, off-the-shelf CAR T cells is a promising approach for relapsed leukemia, with potential implications for the future of gene therapy.